283 related articles for article (PubMed ID: 28395740)
1. Generation and characterization of two iPSC lines from human epicardium-derived cells.
Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J
Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
[TBL] [Abstract][Full Text] [Related]
2. Characterization of iPSCs derived from dermal fibroblasts from a healthy 19year old female.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):597-599. PubMed ID: 27934589
[TBL] [Abstract][Full Text] [Related]
3. Characterization of dermal fibroblast-derived iPSCs from a patient with low grade steatosis.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):547-549. PubMed ID: 27789406
[TBL] [Abstract][Full Text] [Related]
4. Lymphoblast-derived integration-free iPSC lines from a female and male Alzheimer's disease patient expressing different copy numbers of a coding CNV in the Alzheimer risk gene CR1.
Schröter F; Sleegers K; Van Cauwenberghe C; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):560-563. PubMed ID: 27789410
[TBL] [Abstract][Full Text] [Related]
5. Characterization of dermal fibroblast-derived iPSCs from a patient with high grade steatosis.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):568-571. PubMed ID: 27789412
[TBL] [Abstract][Full Text] [Related]
6. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
[TBL] [Abstract][Full Text] [Related]
7. Episomal plasmid-based generation of an iPSC line from an 83-year-old individual carrying the APOE4/4 genotype: i10984.
Zulfiqar S; Fritz B; Nieweg K
Stem Cell Res; 2016 Nov; 17(3):523-525. PubMed ID: 27789402
[TBL] [Abstract][Full Text] [Related]
8. Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation.
Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):553-555. PubMed ID: 27789408
[TBL] [Abstract][Full Text] [Related]
9. Episomal plasmid-based generation of an iPSC line from a 79-year-old individual carrying the APOE4/4 genotype: i11001.
Zulfiqar S; Fritz B; Nieweg K
Stem Cell Res; 2016 Nov; 17(3):544-546. PubMed ID: 27789405
[TBL] [Abstract][Full Text] [Related]
10. Lymphoblast-derived integration-free ISRM-CON9 iPS cell line from a 75year old female.
Martins S; Bohndorf M; Schröter F; Assar F; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2018 Jan; 26():76-79. PubMed ID: 29268155
[TBL] [Abstract][Full Text] [Related]
11. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
[TBL] [Abstract][Full Text] [Related]
12. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
[TBL] [Abstract][Full Text] [Related]
13. Generation of iPSC line iPSC-FH2.1 in hypoxic conditions from human foreskin fibroblasts.
Questa M; Romorini L; Blüguermann C; Solari CM; Neiman G; Luzzani C; Scassa MÉ; Sevlever GE; Guberman AS; Miriuka SG
Stem Cell Res; 2016 Mar; 16(2):300-3. PubMed ID: 27345989
[TBL] [Abstract][Full Text] [Related]
14. Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).
Xiong K; Zhou Y; Hyttel P; Bolund L; Freude KK; Luo Y
Stem Cell Res; 2016 Nov; 17(3):665-669. PubMed ID: 27934604
[TBL] [Abstract][Full Text] [Related]
15. Lymphoblast-derived integration-free iPS cell line from a 65-year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2016 Jan; 16(1):113-5. PubMed ID: 27345793
[TBL] [Abstract][Full Text] [Related]
16. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC.
Jung-Klawitter S; Blau N; Sebe A; Ebersold J; Göhring G; Opladen T
Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587
[TBL] [Abstract][Full Text] [Related]
17. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
18. Generation of induced pluripotent stem cell line from foreskin fibroblasts.
Skrzypczyk A; Giri S; Bader A
Stem Cell Res; 2016 Nov; 17(3):572-575. PubMed ID: 27789413
[TBL] [Abstract][Full Text] [Related]
19. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
[TBL] [Abstract][Full Text] [Related]
20. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
